medicaid covered glp 1 covers GLP-1 meds for obesity in just 13 states, analysis finds Medicare and Medicaid to Start
Description
The inflammation-cardiovascular connection deserves deeper exploration

In addition to GLP-1s now well-known ability to treat diabetes and obesity, Al-Aly and his team found connections between GLP-1 use and reduced risk of substance use disorders, suicidal ideation, seizures, dementia and Alzheimers disease, among many others

"We recognized that patients needed more than just a tracking tool - they needed a comprehensive support system that evolves with their treatment journey," explains Javi d'Erausquin, Co-Founder of Gala

These actions of semaglutide are described in experiments in obese mice
Lancet 2023;402:529-544

SD: Sprague-Dawley
